Off-the-Shelf CAR t cells show promise for Hard-to-Treat lymphoma
NCT ID NCT04416984
First seen Mar 15, 2026 · Last updated May 17, 2026 · Updated 10 times
Summary
This study tests a new type of CAR T cell therapy called ALLO-501A, which is made from donor cells and does not need to be custom-made for each patient. It is for adults with large B-cell lymphoma or chronic lymphocytic leukemia/small lymphocytic lymphoma that has come back or not responded to standard treatments. The goal is to see if this therapy is safe and effective at shrinking or eliminating cancer, while also monitoring side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY LARGE B CELL LYMPHOMA, RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA, RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advent Health
Orlando, Florida, 06510, United States
-
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212, United States
-
Augusta University
Augusta, Georgia, 30912, United States
-
Avera Medical
Sioux Falls, South Dakota, 57117, United States
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
CHU de Québec -Université Laval; Hôpital de l'Enfant-Jésus
Québec, Quebec, G1J 1Z4, Canada
-
City of Hope
Duarte, California, 91010, United States
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218-1234, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Loyola University Medical Center
Maywood, Illinois, 60153, United States
-
MD Anderson Cancer Center - University of Texas
Houston, Texas, 77030, United States
-
Mayo Clinic Hospital
Phoenix, Arizona, 85054, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612-9416, United States
-
Monash Medical Centre
Clayton, Victoria, 3168, Australia
-
Northside Hospital - Atlanta
Atlanta, Georgia, 30342, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40207, United States
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
QEII Health Sciences Centre-VG Site
Halifax, Nova Scotia, B3H 2Y9, Canada
-
St. David's South Austin Medical Center
Austin, Texas, 78704, United States
-
St. Vincent's Hospital Melbourne
Fitzroy, Victoria, 3065, Australia
-
Stanford Cancer Institute
Palo Alto, California, 94035, United States
-
Texas Oncology
Dallas, Texas, 75251, United States
-
UCLA Medical Center
Los Angeles, California, 90095, United States
-
University of Miami
Miami, Florida, 33136, United States
-
Vanderbilt Ingram Cancer Center
Nashville, Tennessee, 37232, United States
-
Yale School of Medicine
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.